The development or identification of compounds like ADN-368 often occurs within the context of medical research, particularly in the search for new drugs or therapeutic agents. These compounds can be involved in various stages of research, from initial discovery and preclinical studies through to clinical trials and, if successful, regulatory approval and market release.
It began with a simple goal: to create a human being capable of surviving in the harshest environments on Earth. The team at Alpha-4 had made tremendous breakthroughs in gene editing, using CRISPR technology to rewrite the fundamental code of life. But as the project progressed, the objectives expanded. The scientists were no longer just talking about survival; they were talking about enhancement. ADN-368